# Development of Immune Globulin Treatment for Avian Flu

> **NCT00383071** · PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 126 (actual)

## Conditions studied

- Infectious Diseases
- Influenza
- Avian Flu

## Interventions

- **BIOLOGICAL:** H5N1 vaccine
- **PROCEDURE:** Apheresis

## Key facts

- **NCT ID:** NCT00383071
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** 2010-03
- **Final completion:** 2014-12
- **Target enrollment:** 126 (ACTUAL)
- **Why stopped:** Cannot get enough plasma to manufacture IVIG for human trials
- **Last updated:** 2018-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00383071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00383071, "Development of Immune Globulin Treatment for Avian Flu". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00383071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*